Gsa Capital Partners LLP Mirum Pharmaceuticals, Inc. Transaction History
Gsa Capital Partners LLP
- $1.11 Billion
- Q1 2025
A detailed history of Gsa Capital Partners LLP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 40,459 shares of MIRM stock, worth $1.78 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
40,459
Previous 54,123
25.25%
Holding current value
$1.78 Million
Previous $2.24 Million
18.54%
% of portfolio
0.16%
Previous 0.17%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
224Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$299 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$210 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$142 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$123 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$112 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.62B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...